Microvalves are important flow-control devices in many standalone and integrated microfluidic applications. Polydimethylsiloxane (PDMS)-based pneumatic microvalves are commonly used but they generally require large peripheral connections that decrease portability. There are many alternatives found in the literature that use Si-based microvalves, but variants that can throttle even moderate pressures (1 bar) tend to be bulky (cm-range) or consume high power. This paper details the development of a low-power, normally-open piezoelectric microvalve to control flows with a maximum driving pressure of 1 bar, but also retain a small effective form-factor of 5 mm × 5 mm × 1.8 mm. A novel combination of rapid prototyping methods like stereolithography and laser-cutting have been used to realize this device. The maximum displacement of the fabricated piezoelectric microactuator was measured to be 8.5 μm at 150 V. The fabricated microvalve has a flow range of 0–90 μL min⁻¹ at 1 bar inlet pressure. When fully closed, a leakage of 0.8% open-flow was observed with a power-consumption of 37.5 μW. A flow resolution of 0.2 μL min⁻¹—De-ionized (DI) water was measured at 0.5 bar pressure.

Microfluidic organs-on-chips (OoCs) technology has emerged as the trend for in vitro functional modeling of organs in recent years. Simplifying the complexities of the human organs under controlled perfusion of required fluids paves the way for accurate prediction of human organ functionalities and their response to interventions like exposure to drugs. However, in the state-of-the-art OoC, the existing methods to control fluids use external bulky peripheral components and systems much larger than the chips used in experiments. A new generation of compact microfluidic flow control systems is needed to overcome this challenge. This study first presents a structured classification of OoC devices according to their types and microfluidic complexities. Next, we suggest three fundamental fluid flow control mechanisms and define component configurations for different levels of OoC complexity for each respective mechanism. Finally, we propose an architecture integrating modular microfluidic flow control components and OoC devices on a single platform. We emphasize the need for miniaturization of flow control components to achieve portability, minimize sample usage, minimize dead volume, improve the flowing time of fluids to the OoC cell chamber, and enable long-duration experiments.

Being one of the major pillars of liquid biopsy, isolation and characterization of circulating tumor cells (CTCs) during cancer management provides critical information on the evolution of cancer and has great potential to increase the success of therapies. In this article, we define a novel strategy to effectively enrich CTCs from whole blood based on size, utilizing a spiral microfluidic channel embedded with a hydrofoil structure at the downstream of the spiral channel. The hydrofoil increases the distance between the streams of CTCs and peripheral blood cells, which are already distributed about two focal axes by the spiral channel, thereby improving the resolution of the separation. Analytical validation of the system has been carried out using Michigan Cancer Foundation-7 (MCF7) breast cancer cell lines spiked into blood samples from healthy donors, and the performance of the system in terms of white blood cell (WBC) depletion, CTC recovery rate and cell viability has been shown in single or two-step process: by passing the sample once or twice through the microfluidic chip. Single step process yielded high recovery (77.1%), viable (84.7%) CTCs. When the collected cell suspension is re-processed by the same chip, recovery decreases to 65.5%, while the WBC depletion increases to 88.3%, improving the purity. Cell viability of >80% was preserved after two-step process. The novel microfluidic chip is a good candidate for CTC isolation applications requiring high recovery rate and viability, including functional downstream analyses for variety of cancer types.

Reciprocating piezoelectric micropumps enable miniaturization in microfluidics for lab-on-a-chip applications such as organs-on-chips (OoC). However, achieving a steady flow when using these micropumps is a significant challenge because of flow ripples in the displaced liquid, especially at low frequencies or low flow rates (<50 µL/min). Although dampers are widely used for reducing ripples in a flow, their efficiency depends on the driving frequency of the pump. Here, we investigated multi-phase rectification as an approach to minimize ripples at low flow rates by connecting piezoelectric micropumps in parallel. The efficiency in ripple reduction was evaluated with an increasing number (n) of pumps connected in parallel, each actuated by an alternating voltage waveform with a phase difference of 2π/n (called multi-phase rectification) at a chosen frequency. We introduce a fluidic ripple factor ($R{F}_{fl.}$), which is the ratio of the root mean square ($RMS$) value of the fluctuations present in the rectified output to the average fluctuation-free value of the discharge flow, as a metric to express the quality of the flow. The fluidic ripple factor was reduced by more than 90% by using three-phase rectification when compared to one-phase rectification in the 2–60 μL/min flow rate range. Analytical equations to estimate the fluidic ripple factor for a chosen number of pumps connected in parallel are presented, and we experimentally confirmed up to four pumps. The analysis shown can be used to design a frequency-independent multi-phase fluid rectifier to the desired ripple level in a flow for reciprocating pumps.

Circulating tumor cells (CTCs) are valuable biomarkers for cancer diagnosis and monitoring, yet their isolation from blood remains challenging due to their phenotypic heterogeneity and rarity. Label-free microfluidic technologies offer a promising alternative to affinity-based approaches by exploiting intrinsic biophysical differences between cell types. Here, we developed a microfluidic platform for label-free cell separation based on insulator-based dielectrophoresis (iDEP). The microfluidic device employs an array of triangular insulating structures that generate strong electric field gradients in response to an externally applied alternating current (AC) electric field, enabling selective isolation of breast cancer cells from blood cells based on their dielectric properties. Hydrodynamic focusing is used to confine the sample stream and precisely control cell trajectories within the separation region. Numerical simulations were performed to optimize the electric field distribution and fluid flow characteristics within the device. Experimental validation using breast cancer cell lines (mesenchymal-like MDA-MB-231 cells and epithelial-like MCF-7 cells) spiked into peripheral blood mononuclear cells (PBMCs) demonstrates selective dielectrophoretic deflection of cancer cells while PBMCs largely follow the central streamline. The platform achieves recovery rates exceeding 98% and a separation purity above 65% within the optimized operating conditions. The proposed system provides a simple label-free approach to separate heterogeneous cell populations and represents a promising tool for microfluidic liquid biopsy enrichment applications.